also showed that overexpression of MYBL2 can promote the proliferation of non-small cell lung carcinoma (NSCLC) cells, and that the ERK and Akt signaling pathways are involved in the regulation of MYBL2 in NSCLC (34). This evidence concerns the gene AKT1 and non-small cell lung carcinoma.